General Safety of Febuxostat and Allopurinol in a Cardiovascular Outcomes Study in Patients with Gout

被引：0
|
作者：
Saag, Kenneth [1 ]
Becker, Michael A. [2 ]
White, William B. [3 ]
Whelton, Andrew [4 ]
Borer, Jeffrey [5 ]
Gorelick, Philip [6 ]
Hunt, Barbara [7 ]
Castillo, Majin [7 ]
Gunawardhana, Lhanoo [7 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[3] Univ Connecticut, Sch Med, Cardiol, Farmington, CT USA
[4] Johns Hopkins Univ, Sch Med, Hunt Valley, MD USA
[5] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
[6] Michigan State Univ, Coll Human Med, Grand Rapids, MI USA
[7] Takeda Pharmaceut Int, Deerfield, IL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
873
引用
收藏
页数：2
相关论文
共 50 条
  • [41] EFFECTS OF ALLOPURINOL VERSUS FEBUXOSTAT ON CARDIOVASCULAR RISK IN KOREAN PATIENTS WITH GOUT: A NATION-WIDE COHORT STUDY
    Shin, A.
    Kim, M. H.
    Ha, Y. -J.
    Lee, Y. J.
    Song, Y.
    Kim, S. C.
    Kang, E. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 143 - 143
  • [42] Febuxostat equals allopurinol for gout prophylaxis
    不详
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2006, 73 (03) : 214 - 214
  • [43] Febuxostat compared with allopurinol in patients with hyperuricemia and gout. Results of the FACT study
    不详
    [J]. KARDIOLOGIYA, 2006, 46 (07) : 79 - 79
  • [44] Women with gout: Efficacy and safety of urate-lowering with febuxostat and allopurinol
    Chohan, Saima
    Becker, Michael A.
    MacDonald, Patricia A.
    Chefo, Solomon
    Jackson, Robert L.
    [J]. ARTHRITIS CARE & RESEARCH, 2012, 64 (02) : 256 - 261
  • [45] Reassessing the Cardiovascular Safety of Febuxostat: Implications of the Febuxostat versus Allopurinol Streamlined Trial
    Choi, Hyon K.
    Neogi, Tuhina
    Stamp, Lisa K.
    Terkeltaub, Robert
    Dalbeth, Nicola
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) : 721 - 724
  • [46] Efficacy and safety of Febuxostat Versus Allopurinol in Hyperuricemic patients with or without Gout: A meta-analysis
    Fan, Bin
    Zhang, Ping
    Li, Xiaoyu
    [J]. NEUROENDOCRINOLOGY LETTERS, 2020, 41 (04) : 195 - 204
  • [47] A COMPARATIVE EVALUATION OF THE HEALTH ECONOMIC OUTCOMES OF FEBUXOSTAT AND ALLOPURINOL IN GOUT PATIENTS WITH CHRONIC KIDNEY DISEASE
    Mitri, G.
    Wittbrodt, E. T.
    Turpin, R. S.
    Costa, L. A.
    Schulman, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 445 - 445
  • [48] Cardiovascular safety assessment of febuxostat and allopurinol in the real world: A retrospective cohort study
    Hung, Pei-Yuan
    Hsieh, Hui-Hsia
    Wu, Tien-Yuan
    Chen, Chi-Hua
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 159 - 159
  • [49] Risk of Cardiovascular Events in Older Patients with Gout Initiating Febuxostat Versus Allopurinol: A Population-Based Cohort Study
    Zhang, MaryAnn
    Liu, Jun
    Kang, Eun Ha
    Desai, Rishi J.
    Neogi, Tuhina
    Solomon, Daniel H.
    Kim, Seoyoung C.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [50] Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study
    Zhang, MaryAnn
    Solomon, Daniel H.
    Desai, Rishi J.
    Kang, Eun Ha
    Liu, Jun
    Neogi, Tuhina
    Kim, Seoyoung C.
    [J]. CIRCULATION, 2018, 138 (11) : 1116 - 1126
12345